Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by DJDawgon Nov 28, 2021 7:30pm
638 Views
Post# 34174288

re NMIBC update...coming.

re NMIBC update...coming.
I'm sure that this is obvious but we could be due for a whole 6 new patient updates reaching 90 days. If there were 6 pending as of Aug 30 then they should be there. Does that sound about right? And we should have better 180 day data around durability for the previous 90 day CR patients.

As Enrique summarizes well, as of the Aug 30 update, there are 14 patients who have ever recieved the optimized full deal (treatment and procedure).

The margin of error on a sample of 14 patients is 26% (95% conf). In other words, for 14 patients the information that they would tell us about the PR/CR of a hypothetical long term group of 100,000 patients is plus or minus 26%.

So far we are at 1NR (perhaps truly a CR who passed away too early), 1 PR and 6 CR. This means 87.5% some response (PR and CR).

Statistically, if we add the data on the new 6 and they play out in different ways these are the true long term ranges for what a large group would do (in terms of any response to one treatment,90 days).

new 6 PR or CR     new PR or CR for optimized ever     Range of true large pop 90d PR or CR
6/6                          13/14                                                  66-100%
5/6                          12/14                                                  59-100%
4/6                           11/14                                                 52-100%
3/6                           10/14                                                 45-97%
2/6                           9/14                                                   38-90%
1/6                           8/14                                                   31-83%
0/6                           7/14                                                   24-76%

The lower part of the range is the worst expected large population response. So if 4,5 or 6 are PR or CR then the worst case large population response wold be over 50% off one treatment.

I'm not a stats person but this is my rudimentary take.

My plan is to take the new data, when it comes, plug into above and see what is what for the long term hold.

My hunch is that Vera's hiring process, or wooing/recruiting process would have included an NDA and some additional data known only to the company since Aug 30. She seems like a catch who wouldn't have jumped on to a microcap, penny stock company without doing something equivalent stats to above. IMO

Good luck to all.

ps: let me know if my basic stats knowledge above is erroneous.
<< Previous
Bullboard Posts
Next >>